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Introduction
Active and complex signaling is involved both in the growth of new 
vessels and their stabilization and maintenance. Blood vessel stabi-
lization encompasses proliferation arrest, restoration of the vascu-
lar barrier function, and acquisition of mural cell coverage. These 
properties need to be maintained for the lifetime of the organism 
to ensure optimal perfusion and tissue homeostasis (1). Laminar 
blood flow is an important vessel-stabilizing factor: it contributes 
to the termination of angiogenic signaling and vessel specialization 
through oxygenation of tissues and mechanoregulation of endo-
thelial cells (2). In contrast, disturbed blood flow induces endothe-
lial dysfunction, involving proinflammatory signaling, enhanced 
proliferation, and apoptosis, which ultimately lead to pathological 
responses like the formation of atherosclerotic lesions (2).
In addition, blood vessel stability and integrity require mature 
cell-cell junctions and mural cell coverage. Molecular players impli-
cated in the regulation and maintenance of vascular stability include 
ANG1/TIE2, FGF, Notch, S1P, PDGF-β and TGF-β signaling, extra-
cellular matrix, and proteases. Important progress has already been 
achieved in our understanding of the molecular regulation of blood 
vessel stability (3). However, little is known about the processes 
involved in stabilization of the lymphatic vasculature, despite its key 
role in normal homeostasis and in a variety of pathological condi-
tions, such as tumor metastasis and chronic inflammation (4).
The lymphatic vasculature comprises two structurally and func-
tionally distinct compartments: capillaries and collecting vessels. 
Interstitial fluid and immune cells enter via discontinuous intercellu-
lar junctions in lymphatic capillaries and are transported by collect-
ing vessels to lymph nodes as a result of coordinated contractions of 
vascular smooth muscle cells, valve opening, and closure cycles and 
pressure gradients from surrounding tissues (5). Such functional sep-
aration is critically important for optimal lymphatic function (6, 7); 
yet how it is maintained throughout life remains to be defined.
Here, we interrogated the molecular mechanisms of postnatal 
collecting lymphatic vessel maintenance. We showed that collect-
ing lymphatic vessel function requires continuous expression of 
the forkhead transcription factor FOXC2 in areas of disturbed flow, 
such as lymphatic valves. FOXC2 controls endothelial cytoskeleton 
organization and thus ensures cell-cell junction stability, endothe-
lial integrity, and cell-cycle arrest under disturbed flow conditions. 
Biomechanical forces, such as fluid shear stress, govern multiple aspects of endothelial cell biology. In blood vessels, 
disturbed flow is associated with vascular diseases, such as atherosclerosis, and promotes endothelial cell proliferation 
and apoptosis. Here, we identified an important role for disturbed flow in lymphatic vessels, in which it cooperates with the 
transcription factor FOXC2 to ensure lifelong stability of the lymphatic vasculature. In cultured lymphatic endothelial cells, 
FOXC2 inactivation conferred abnormal shear stress sensing, promoting junction disassembly and entry into the cell cycle. 
Loss of FOXC2-dependent quiescence was mediated by the Hippo pathway transcriptional coactivator TAZ and, ultimately, 
led to cell death. In murine models, inducible deletion of Foxc2 within the lymphatic vasculature led to cell-cell junction 
defects, regression of valves, and focal vascular lumen collapse, which triggered generalized lymphatic vascular dysfunction 
and lethality. Together, our work describes a fundamental mechanism by which FOXC2 and oscillatory shear stress maintain 
lymphatic endothelial cell quiescence through intercellular junction and cytoskeleton stabilization and provides an essential 
link between biomechanical forces and endothelial cell identity that is necessary for postnatal vessel homeostasis. As FOXC2 
is mutated in lymphedema-distichiasis syndrome, our data also underscore the role of impaired mechanotransduction in the 
pathology of this hereditary human disease.
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tions, which mimic disturbed flow (11). We first analyzed the tran-
scriptome of LECs subjected to OSS, in the presence or absence 
of FOXC2 (control or FOXC2KD cells, respectively), and compared 
them to cells cultured under static conditions (Figure 2A and 
Supplemental Figure 1A; supplemental material available online 
with this article; doi:10.1172/JCI80454DS1). In control cells, OSS 
affected the expression of over 800 genes (FDR < 0.05, Figure 
2B and see validation by qPCR in Supplemental Figure 1, B–D). 
Analysis of Kyoto Encyclopedia of Genes and Genomes (KEGG) 
pathways (12, 13) revealed important rewiring of LEC metabolism 
by OSS, as demonstrated by activation of steroid and terpenoid 
backbone biosynthesis, glutathione metabolism, and the pentose 
phosphate pathway (Supplemental Table 1). Surprisingly, cell cycle 
and mitosis pathways were the most significantly repressed KEGG 
pathways, as evidenced by a concerted decreased expression 
of genes associated with cell-cycle progression (Supplemental 
Table 1). This result was unexpected, as disturbed flow is a known 
inducer of proliferation in blood endothelial cells (BECs) (11).
FOXC2 inactivation modified the expression of 35% of the shear 
stress–responsive genes, demonstrating that FOXC2 regulates a sig-
nificant proportion of LEC shear stress transcriptional responses 
(Figure 2B). FOXC2KD cells demonstrated an abnormal shear stress 
response, as observed by reduced expression of known shear stress–
responsive genes, such as eNOS and CX37 (refs. 10, 14, and Supple-
mental Figure 1, B and C). Most strikingly, cell-cycle progression 
genes were no longer repressed by OSS in FOXC2KD cells, suggesting 
that cells fail to undergo growth arrest (Figure 2, C and D, and Sup-
plemental Figure 1, E and F). In contrast, FOXC2 knockdown did not 
affect OSS-dependent suppression of the genes related to immune 
responses or OSS-dependent induction of the genes related to cho-
lesterol biosynthesis (Figure 2, C and D), suggesting a specific role 
of FOXC2 in the OSS-induced downregulation of cell proliferation.
We next analyzed LEC proliferation in static and OSS condi-
tions by staining for the proliferation marker Ki67 (Figure 3, A and 
B). Low but detectable proliferation of LECs in static conditions 
was significantly decreased by OSS (Figure 3B). Surprisingly, but 
in agreement with the transcriptome analyses (Figure 2, C and D), 
FOXC2KD cells displayed a 10-fold increase in the number of Ki67+ 
cells in OSS when compared with that of control cells. This finding 
was further confirmed by the analysis of DNA synthesis and the 
use of a second FOXC2 siRNA (Supplemental Figure 2, A–C).
In BECs, disturbed flow induces not only cell proliferation, but 
also cell death (11). To study whether FOXC2 regulates cell survival, 
we stained cells for the apoptosis marker activated caspase-3. How-
ever, we could not detect any apoptotic cells under OSS (data not 
shown), likely due to their rapid elimination by the flow. To overcome 
this limitation, we performed a time-lapse microscopy analysis. We 
found that OSS induced the death and quick detachment of some 
We further showed that FOXC2 secures cell dormancy by blocking 
proliferation mediated by the mechanosensitive Hippo pathway 
transcriptional coactivator TAZ. Our work establishes a general 
principle of postnatal lymphatic vascular organization in which 
FOXC2 plays a central role in maintaining collecting vessel quies-
cence and stability, notably in valve areas, by linking shear stress 
responses to cell junction stabilization and cell-cycle arrest. FOXC2 
is mutated in lymphedema-distichiasis, a debilitating human dis-
ease, characterized by lymphedema of the lower limbs and valve 
defects (8). Our work now provides a robust mouse model, in which 
the rapid onset of lymphatic vascular dysfunction makes it espe-
cially suitable for therapeutic preclinical studies.
Results
FOXC2 is highly expressed in areas of flow recirculation. FOXC2 plays 
an important role in the initiation of embryonic collecting lym-
phatic vessel formation (7, 9). We found that FOXC2 continues to be 
highly expressed in the postnatal collecting lymphatic vessels (Fig-
ure 1A). In agreement with the previously demonstrated induction 
of FOXC2 expression by oscillatory shear stress (OSS) in vitro (10), 
FOXC2 levels were highest in endothelial cells of the valve sinuses 
(Figure 1A), which are exposed to disturbed flow patterns (11). 
FOXC2 was low in the parts of the valve leaflets exposed to lami-
nar shear stress (Figure 1A) and in capillary or pre-collecting vessel 
lymphatic endothelial cells (LECs) (Figure 1B), whereas cells in 
lymphangions expressed intermediate levels of FOXC2 (Figure 1A).
FOXC2 regulates shear stress–induced quiescence and survival. 
To analyze whether FOXC2 regulates responses to disturbed flow, 
we studied LECs cultured under static or oscillatory flow condi-
Figure 1. FOXC2 expression pattern in postnatal lymphatic vessels. (A) 
In P8 mesenteric lymphatic vessels FOXC2 (green) is highly expressed in 
the valve sinuses subjected to recirculating flow, while only low levels are 
found on the upstream luminal part of the valve exposed to laminar shear 
stress. PROX1 (red) is strongly expressed on both sides of the valve leaflet. 
(B) FOXC2 levels are low in P8 intestinal lymphatic capillaries, and only 
occasional FOXC2+ cells are detected in submucosal pre-collecting vessels. 
Intestinal villus is outlined with a dotted line. The arrowheads indicate 
FOXC2+ cells. Scale bars: 50 μm.
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and Supplemental Videos 5 and 6), suggesting stabilization of the 
endothelial monolayer. In contrast, although FOXC2KD LECs were 
less motile in static conditions, they migrated more in OSS (Figure 
3E, Supplemental Figure 2D, and Supplemental Videos 7 and 8).
Thus, we conclude that in LECs OSS triggers growth and motility 
arrest, which may protect vessel integrity by reducing the cell turn-
over (Figure 3F). Of interest, although further studies are warranted, 
our data suggest that LECs respond differently to disturbed flow in 
comparison to BECs (11). Most importantly, FOXC2 plays a key role 
in such LEC responses, suggesting that FOXC2 acts as a guardian of 
LEC quiescence and survival in disturbed flow conditions.
control cells (Figure 3, C and D, and Supplemental Videos 1 and 2). 
Importantly, we observed increased proliferation of FOXC2KD cells 
under OSS, which was also accompanied by increased cell death 
(Figure 3, C and D, and Supplemental Videos 3 and 4).
Endothelial cells actively migrate during sprouting (lymph)
angiogenesis, whereas the motility of endothelial cells in quies-
cent vessels is reduced, which is important for overall vessel sta-
bility (3). To evaluate whether FOXC2 plays a role in LEC motil-
ity, we tracked the movement of control and FOXC2KD cells in 
the presence and absence of OSS. LECs were highly motile under 
static conditions and became immobilized under OSS (Figure 3E 
Figure 2. FOXC2 represses a proliferative genetic program in LECs under disturbed flow conditions. (A) Flowchart of the experiments for in vitro FOXC2 
knockdown in LECs, shear stress treatment, and gene expression analysis. (B) Scatter plot of global changes in gene expression induced by OSS in control 
and FOXC2KD cells. Colored dots indicate transcripts changed in the indicated conditions (n = 2; regularized t test, FDR < 0.05); black dots indicate stable 
transcripts. Downregulated and upregulated genes appear on the left and right sides of the plot, respectively. The numbers of transcripts significantly 
regulated in both control and FOXC2KD cells (pink), only in control cells (green), and only in FOXC2KD cells (blue) are indicated on the plot. (C and D) Protein 
interaction networks for genes (C) repressed or (D) induced by OSS in control or FOXC2KD cells. The number of genes for each condition is indicated. Genes 
associated with cell cycle, immune responses, or cholesterol biosynthesis are highlighted, with the corresponding colored dots on the networks. Dot size 
reflects the degree of changes for each transcript. Data are obtained from 2 independent experiments (see also Supplemental Figure 1).
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Exposure to OSS resulted in the transformation of such linear junc-
tions into overlapping contact sites, often assembled into a com-
plex reticular adherens network (Figure 4, A–C), which has been 
previously described in quiescent BECs (17). Taken together with 
the fact that OSS induces LEC quiescence and motility arrest, this 
observation suggests that OSS stabilizes cell-cell junctions. Induc-
FOXC2 controls cell-cell junction and cytoskeleton organization in 
a cell-autonomous manner. Given the known relevance of cell-cell 
junctions in contact inhibition of growth (15), we next analyzed 
whether FOXC2 regulates lymphatic endothelial intercellular junc-
tions. As previously described (16), control LECs displayed mostly 
linear intercellular junctions in static conditions (Figure 4, A–C). 
Figure 3. FOXC2 controls the quiescent state and survival of LECs under disturbed flow conditions. (A) FOXC2KD cells proliferate more under OSS. 
Staining for FOXC2 (pink), VE-cadherin (white), and proliferation marker Ki67 (green). (B) Quantification of Ki67+ cells in A in the indicated conditions. 
(C) FOXC2KD cells have an increased death rate under OSS. Time-lapse microscopy images of control and FOXC2KD cells. White arrowheads indicate dying 
cells. (D) Quantification of dying cells in C over 4 hours of recording. (E) Increased motility of FOXC2KD cells under OSS. Cell trajectory plots of individual 
control (blue) or FOXC2KD (orange) cells in static or OSS conditions. (F) Scheme showing control or FOXC2KD cell phenotype under OSS. Control cells become 
quiescent, while FOXC2KD cells show increased proliferation, motility, and death. Scale bars: 10 μm. n = 3; more than 50 cells scored per condition; 2-tailed 
unpaired Student’s t test; #P < 0.05 (static vs. OSS), *P < 0.05 (control vs. FOXC2KD) (see also Supplemental Figure 2 and Supplemental Videos 1–8).
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OSS induced the formation of thick cortical actin stress fibers 
(ref. 10 and Figure 5A). The density of actin fibers was increased 
upon FOXC2 knockdown in static conditions, and this was fur-
ther drastically enhanced under OSS (Figure 5A). Staining for 
the phosphorylated myosin light chain 2 (pMLC2), an indicator 
of actomyosin contractility, was rather weak in control cells, 
even under OSS (Figure 5A). In contrast, actin fibers were asso-
ciated with increased pMLC2 in FOXC2KD cells (Figure 5A), sug-
gesting greater contractile forces in these cells under disturbed 
flow conditions. Further analyses demonstrated a close associ-
ation of VE-cadherin with actin stress fibers in FOXC2KD zigzag 
cell-cell junctions (Supplemental Figure 3C), suggesting that 
stress fiber contractility on each side of the junction causes VE-
cadherin zigzag patterning. Therefore, it is possible that junc-
tion stability is maintained by a FOXC2-dependent fine-tuning 
of the intercellular tensional cytoskeletal forces and regulation 
of RhoA/ROCK/MLC signaling.
We also analyzed the distribution of vinculin, which anchors 
actin fibers to focal adherens junctions between cells or focal 
adhesions to the cell matrix. Vinculin is a mechanosensing pro-
tein, which controls force-dependent junction remodeling by 
integrating the cytoskeleton tensional forces and protecting junc-
tion of overlapping cell-cell junctions and growth arrest was spe-
cific to OSS, as LECs under laminar shear stress displayed mostly 
linear cell-cell junctions and a somewhat increased proliferation 
(Supplemental Figure 2, E and F). FOXC2 knockdown resulted in 
partial disruption of the continuous VE-cadherin staining pattern 
in LECs under static conditions, which was transformed into a zig-
zag-like junctional structure (Figure 4, A–C). Importantly, this phe-
notype was further strongly potentiated by OSS (Figure 4, A–C). 
There was a general reduction of the junctional area (Figure 4D) 
associated with an increased junction complexity (Figure 4E) and 
an increased number of interendothelial gaps (Figure 4F). Staining 
for β-catenin, which links VE-cadherin to the actin cytoskeleton, 
and a marker of tight junctions, ZO-1, revealed similar linear or zig-
zag-like patterns of junctions in control and FOXC2KD cells, respec-
tively (Supplemental Figure 3, A and B). Importantly, in partial 
knockdown experiments, FOXC2+ cells maintained overlapping 
junctions, whereas surrounding FOXC2– cells had zigzag junctions, 
demonstrating that FOXC2 protects junctions cell autonomously 
and not in a paracrine manner (Figure 4G).
We further examined organization of the actin cytoskele-
ton in control and FOXC2KD cells. As previously described, cells 
under static conditions had only a thin rim of cortical actin, and 
Figure 4. FOXC2 and OSS control adherens cell-cell junction integrity. (A) Staining of control and FOXC2KD cells for FOXC2 (green) and VE-cadherin (pink). 
The arrow indicates an overlapping junction induced by OSS; the arrowhead indicates a zigzag-like junction induced by FOXC2 depletion. Cell nuclei are 
outlined by white lines. (B) High-magnification images of VE-cadherin junctions (black) show the formation of reticular structures (red arrow) in control 
cells under OSS, while FOXC2KD cells have mostly discontinuous and thin cell-cell contacts (red arrowhead). (C) Quantification of adherens cell-cell junction 
types in control and FOXC2KD cells. VE-cadherin+ junctions were classified as linear (exemplified by control/static image in B), overlapping (exemplified by 
control/oscillatory image in B), or discontinuous (exemplified by FOXC2KD/oscillatory image in B). The proportion of each junction type was determined for 
the entire cell periphery. (D) OSS increases VE-cadherin+ junctional area in control but not in FOXC2KD LECs. (E) Increased junction complexity in FOXC2KD 
cells, as indicated by increased fractal dimension of the VE-cadherin organization. (F) Increased number of VE-cadherin– gaps in FOXC2KD LECs. (G) FOX-
C2-dependent cell-cell junction remodeling is cell autonomous. The isolated FOXC2+ cell has continuous junctions (arrows), while the neighboring FOXC2KD 
cells have zigzag junctions (arrowheads). Staining for FOXC2 (green) and VE-cadherin (pink). Cell nuclei are outlined with dashed white lines. Scale bars: 10 
μm (A and G); 5 μm (B). n = 3; more than 50 cells scored per condition; 2-tailed unpaired Student’s t test; #P < 0.05 (static vs. OSS), *P < 0.05 (control vs. 
FOXC2KD) (see also Supplemental Figure 3, A and B).
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tions from disrupting under such forces (18). Vinculin levels were 
augmented in junctional areas between FOXC2KD cells when com-
pared with control cells, suggesting higher intercellular traction 
forces and loss of junction integrity (Figure 5B).
In conclusion, LECs normally adapt to oscillatory flow by rein-
forcing cell-cell junctions. Such increased overlapping interaction 
surface, associated with cortical actin cytoskeleton at the cell-cell 
junction, is likely important for providing resistance to mechani-
cal stress. Loss of FOXC2 prevents the formation of overlapping 
junctions and leads to profound remodeling of the cell cytoskele-
ton, increased actomyosin contractility, and formation of discon-
tinuous cell-cell junctions, prone to disruption when subjected to 
mechanical forces (Figure 5C). Thus, we propose that FOXC2 is 
necessary for stabilization of cell-cell junctions and the ability of 
cells to withstand mechanical stress.
FOXC2 buffers YAP1/TAZ signaling in LECs. FOXC2-depleted 
LECs respond to OSS by cytoskeleton hypercontractility, intercel-
lular junction disruption, aberrant proliferation, and, ultimately, 
increased cell death. We hypothesized that the observed cytoskel-
etal and junctional changes relieve the contact inhibition, thus 
initiating proliferation of FOXC2KD cells. Mechanotransduction 
regulates cell proliferation via cytoplasmic versus nuclear localiza-
tion of YAP1/TAZ transcriptional coactivators, which can also be 
sequestered by junction molecules, such as catenins and angiomo-
tins (19, 20). Contact inhibition of cell growth is triggered through 
inactivation of YAP1/TAZ, whereas low cell density or loss of cell-
cell contacts induces nuclear translocation of YAP1/TAZ and sub-
sequent activation of cell cycle (15, 21).
Analyses of genes regulated by OSS in the presence or absence 
of FOXC2 revealed that FOXC2KD cells expressed higher levels 
of YAP1/TAZ target genes CTGF, CYR61, and ANKRD1 (22), and 
this effect was further potentiated under OSS (Figure 6A), suggest-
ing that FOXC2 restricts the activation of YAP1/TAZ signaling by 
oscillatory flow. Staining of LECs demonstrated that OSS increased 
nuclear localization of YAP1/TAZ in both control and FOXC2KD 
cells (Figure 6, B and C). However, while YAP1/TAZ was detected 
in control cell-cell junctions, it was mostly nuclear and absent from 
junctions in FOXC2KD cells (Figure 6B and Supplemental Figure 4A). 
These results were in line with in vivo analyses, which demonstrated 
nuclear localization of TAZ and YAP1 in lymphatic valves (Figure 6D 
and data not shown). To study whether YAP1/TAZ play a functional 
role in FOXC2KD cells, we silenced YAP1 and TAZ in FOXC2-depleted 
cells and analyzed cell proliferation in OSS by staining for Ki67. We 
found that YAP1/TAZ knockdown significantly reduced the hyper-
proliferation of FOXC2KD cells (Figure 6E and Supplemental Figure 
4B). Surprisingly, knockdown of YAP1 had no effect on the number 
of Ki67+ cells (Figure 6F), despite significant YAP1 downregulation 
(Supplemental Figure 4C). In contrast, depletion of TAZ with 2 dif-
ferent siRNAs abrogated the aberrant proliferation of FOXC2KD cells, 
without affecting junction organization (Figure 6G and Supplemental 
Figure 4, D–F). Interestingly, TAZ inactivation alone, in addition to 
reducing the expression of the TAZ target genes CTGF, CYR61, and 
ANKRD1 (Supplemental Figure 4G), was sufficient to decrease the 
proliferation of LECs in static conditions (Supplemental Figure 4H).
Collectively, these data highlight the role of cell-cell junctions 
and cytoskeleton organization in the control of LEC quiescence 
Figure 5. FOXC2 and OSS control actin 
cytoskeleton organization. (A) Abnormal 
organization and increased contractility of 
actomyosin in FOXC2KD cells is potentiated 
by OSS. Staining for F-actin (green) and 
pMLC2 (red). (B) FOXC2 depletion and OSS 
enhance vinculin recruitment to the inter-
cellular junctions (arrowheads in FOXC2KD 
vs. arrow in control cells). Staining for vincu-
lin (green). (C) Scheme for the role of FOXC2 
in remodeling of LEC junctions under shear 
stress. OSS induces cortical stress fibers 
and overlapping reticular junctions, whereas 
FOXC2 inactivation leads to aberrant 
accumulation of highly contractile stress 
fibers, junction disruption, and formation of 
interendothelial gaps (see also Supplemen-
tal Figure 3C). Scale bars: 10 μm.
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in response to OSS. These results suggest that, while OSS is able 
to increase YAP1/TAZ nuclear translocation, FOXC2 efficiently 
blocks the pro-proliferative effect of TAZ and thus safeguards LEC 
quiescence and survival under disturbed flow conditions.
FOXC2 is essential for postnatal lymphatic vascular function. To 
assess the role of FOXC2 in the postnatal lymphatic vasculature 
in vivo, we generated a lymphatic endothelial-specific, tamoxifen- 
inducible loss-of-function mouse model (Foxc2fl/fl Prox1-CreERT2 
[Foxc2lecKO]) (Supplemental Figure 5, A–D). Inactivation of Foxc2 led 
to fully penetrant mortality, with the onset varying from a few days 
during early postnatal inactivation to up to 5 months in adult mice 
(Figure 7A and data not shown). Macroscopic analyses demon-
strated development of chylous ascites and chylothorax in Foxc2lecKO 
animals (Figure 7B). Further examination revealed dilated submu-
cosal lymphatic vessels in the small intestine and chyle-filled lym-
phatic vessels in the cecum, which normally does not receive chyle 
because of efficient fat absorption in the duodenum and the jeju-
num (Figure 7C). We also observed Peyer’s patches filled with chyle 
(Figure 7C). Occasionally, chyle-filled lymphatic vessels were also 
observed in other internal organs, such as the heart (Supplemental 
Figure 5E). Mesenteric lymphatic collecting vessels were often sur-
rounded with chyle effusion in Foxc2lecKO animals (Figure 7C).
Figure 6. FOXC2 restricts YAP1/TAZ signaling in LECs under disturbed flow. (A) YAP1/TAZ target genes are over induced in the absence of FOXC2. Heat 
map for the indicated genes (red, increased expression; green, decreased expression). KD, FOXC2KD. (B) YAP1/TAZ accumulate in the nuclei of both control 
and FOXC2KD cells subjected to OSS. Staining for FOXC2 (red), VE-cadherin (green), and YAP1/TAZ (white). Only control cells showed YAP1/TAZ in the 
cell-cell junctions (arrowheads), whereas it was mostly absent from FOXC2KD VE-cadherin+ areas (arrows). Nuclei are outlined with dashed blue lines. 
High-magnification images of the boxed areas are shown in Supplemental Figure 4A. (C) Corresponding quantification of YAP1/TAZ intensity per nucleus 
μm2. (D) Nuclear localization of TAZ in the lymphatic valves. Staining for PROX1 (red) and TAZ (white) of P7 collecting mesenteric vessels. Lymphatic valve 
cells were identified by high PROX1 expression (arrowhead). The vascular lumen (L) is outlined with a dotted blue line and DNA is stained in blue (left), 
and PROX1+ nuclei are outlined with a dotted red line (right). (E–G) Depletion of TAZ, but not YAP1, in FOXC2KD cells reverses hyperproliferation under OSS. 
Quantification of Ki67+ cells in FOXC2KD (orange) and (E) FOXC2/YAP1/TAZ knockdown (green) cells, (F) FOXC2/YAP1 knockdown (purple) cells, or (G) FOX-
C2/TAZ knockdown (red) cells. Scale bars: 10 μm (B); 20 μm (D). n = 3 in C and E; n = 2 in F and G; more than 50 cells scored per condition; 2-tailed unpaired 
Student’s t test; #P < 0.05 (static vs. OSS), *P < 0.05 (control vs. FOXC2KD) (see also Supplemental Figure 4). NS, not significant.
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was confirmed by dye injection into the foot pads or the inguinal 
lymph nodes (Figure 7, D and E). Of interest, Foxc2lecKO collecting 
lymphatic vessels were abnormally patterned, with alternating 
areas of vessel ectasia and constrictions (Figure 7E).
Taken together, these data demonstrate that the continu-
ous expression of FOXC2 is required for postnatal lymphatic 
vascular function.
These data suggested a highly abnormal lymph transport in 
Foxc2lecKO mice. To analyze the lymphatic drainage, we injected 
fluorescent FITC-dextran into the mesenteric lymph nodes of 
control or Foxc2lecKO mice. As expected, we observed filling of the 
thoracic ducts in control mice (Figure 7D). In contrast, Foxc2lecKO 
mice had dye outflow in multiple afferent collecting lymphatic 
vessel branches, indicating lymph backflow. This observation 
Figure 7. FOXC2 is essential for postnatal lymphatic vascular function. (A) Time course of chylous effusion (pink curve) and lethality (green curve) after 
Foxc2 inactivation. The dotted line indicates the time point used for most phenotypic analyses. Chylous effusion was defined as the presence of chylot-
horax or chylous ascites. n = 150 animals (5–20 Foxc2lecKO mice per time point). (B) Macroscopic appearance of chylothorax (top row) and chylous ascites 
(bottom row) in P8 Foxc2lecKO mice. The arrowheads indicate chyle. (C) Chyle accumulation in the intestinal submucosal lymphatic vessels, in the ceca, 
and in Peyer’s patches (asterisk) and chyle leakage from mesenteric lymphatic collecting vessels in P8 Foxc2lecKO mice. Black arrowheads indicate chyle 
accumulation. The white arrow indicates mesenteric vessels. White arrowheads indicate valves. Red arrows indicate chyle leakage. (D) Lymph reflux from 
the thoracic duct and from dermal collecting lymphatic vessels in P8 Foxc2lecKO mice. Collecting lymphatic vessels were visualized by FITC-dextran injec-
tion into the mesenteric lymph node (top row) or the forelimb foot pad (bottom row). Asterisks indicate thoracic ducts. Arrowheads indicate backflow 
into lymphatic branches. FL, forelimb; LN, axillary lymph node. (E) Impaired lymph transport in Foxc2lecKO Prox1-mOrange2+ pups at P8. FITC-dextran was 
injected into the inguinal lymph node (asterisks) and visualized in the dermal efferent collecting vessel. Foxc2lecKO animals often showed arrest of the 
lymph drainage at the site of a misshapen valve with lumen narrowing. Arrowheads indicate valves (see also Supplemental Figure 5). Scale bars: 2 mm 
(B); 250 μm (C); 1 mm (D); 500 μm (E).
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The spectrum of lymphatic valve defects in Foxc2lecKO mice 
ranged from shortened leaflets to an almost complete absence 
of PROX1hi valve cells (Figure 8C), with vessel constriction often 
being the only sign of the former valve location. As Foxc2 dele-
tion in lymphatic valves was nearly complete (Supplemental 
Figure 5D), the variability in the severity of valve defects may 
be related to local conditions, such as changes in flow. Fluores-
cent microlymphangiography demonstrated greatly reduced or 
absent flow through stenotic valve areas, suggesting vessel lumen 
obstruction (Figure 7E). Surprisingly, in a significant proportion 
of Foxc2lecKO vessels, we observed the formation of ectopic sprouts 
extending from the degenerating lymphatic valve sinuses and 
growing in the direction opposite to the normal lymph flow (Fig-
ure 8, C and E). In some cases, such ectopic sprouts further recon-
nected to the main lymphatic vessel, likely providing an alterna-
tive drainage route from the obstructed area.
Foxc2 deletion in older pups (Supplemental Figure 7, A and B) 
or in adult mice (Figure 9A) also led to lymphatic valve degenera-
tion. In adult mice, we observed significantly impaired lymphatic 
valve function, as determined by measuring the pressure required 
to close the valves in isolated mesenteric lymphatic vessels (Fig-
ure 9B and Supplemental Figure 7, C–F). As expected, valves in 
FOXC2 maintains the postnatal collecting lymphatic vessel pheno-
type. We next crossed the Foxc2lecKO line with the Prox1-mOrange2 
reporter strain, which allows better detection of LECs through the 
expression of a fluorescent transgene (refs. 10, 23, and Supple-
mental Figure 5B). In particular, lymphatic valves can be clearly 
identified, due to high levels of Prox1 expression in the leaflets.
Quantification demonstrated that numerous valves were already 
present in mesenteric lymphatic vessels at birth and that their number 
continued to increase during postnatal development, in line with the 
continuous animal growth at this stage (Figure 8A). Control mesen-
teries at P8 showed well-developed collecting lymphatic vessels, 
characterized by even lymphangion diameter, and up to 800 valves 
positioned at regular intervals along the mesenteric vessels (Figure 
8, A and B). Inactivation of Foxc2 induced degeneration of the lym-
phatic valves, leading to a significant decrease both in the total num-
ber of valves and in the proportion of fully formed valves containing 2 
intraluminal leaflets (Figure 8, B–D). The number of valves in Foxc2lecKO 
mice was lower than that at the beginning of tamoxifen administra-
tion, demonstrating that Foxc2 inactivation affects both growing and 
established lymphatic valves (Figure 8D). A similar phenotype was 
observed when using the Flt4-CreERT2 deleter strain to inactivate Foxc2 
in the lymphatic endothelium (Supplemental Figure 6, A–C).
Figure 8. Maintenance of postna-
tal lymphatic valves depends on 
FOXC2. (A) Time course of postna-
tal development and maturation 
of mesenteric lymphatic valves in 
Prox1-mOrange2+ wild-type animals. 
The total valves per mesentery was 
285 ± 24 at P1, 528 ± 90 at P5, and 
756 ± 99 at P8. (B–E) Mice were 
injected with tamoxifen at P4 and 
analyzed at P8. (B) Organization of 
mesenteric lymphatic vasculature in 
P8 mOrange2+ control and Foxc2lecKO 
mice. Arrowheads indicate valves. 
LN, lymph node; Mes, mesentery; 
In, intestine. (C) High-magnification 
images of lymphatic valves shown in 
B. Wild-type valves have a semilunar 
(top row) or a v-like shape (bottom 
row), depending on their orientation. 
Foxc2lecKO valves are disorganized 
and misshapen. The arrow indicates 
a regressing valve. Arrowheads indi-
cate sprouts from the valve site. (D) 
Quantification of the valve number 
and valve leaflet status. (E) Quanti-
fication of sprouts associated with 
Foxc2lecKO lymphatic valves, as shown 
in C. n = 4–6; 4 vessels were scored 
per mesentery; 2-tailed unpaired 
Student’s t test; *P < 0.05. Scale 
bars: 1 mm (B); 50 μm (C).
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explains lymph backflow (Figure 7D), it is not sufficient to account 
for chyle leakage and for the generalized collecting lymphatic vessel 
dysfunction observed in Foxc2lecKO mice.
Endothelial cells in lymphatic capillaries have discontinuous 
cell-cell junctions, which are important for the unimpeded uptake 
of interstitial fluid. In contrast, endothelial cells in collecting ves-
sels are connected by continuous “zipper-like” junctions, which 
minimize the loss of lymph during its transport (27). Junction 
disruption in FOXC2KD cells in vitro and increased lymph leak-
age in Foxc2lecKO mice suggest a loss of vascular barrier integrity 
(Figure 4 and Figure 7C). Therefore, we investigated the state of 
endothelial junctions by staining collecting lymphatic vessels for 
VE-cadherin. Endothelial cells in collecting vessels of wild-type 
mice were elongated in the direction of lymph flow and displayed 
continuous linear cell-cell junctions with high levels of VE-cad-
herin (Figure 11, A and B). However, only 3 days after Foxc2 inac-
tivation, cells already had a more rounded shape (Figure 11, A and 
B). Most importantly, continuous linear cell-cell junctions were 
replaced by distinct zigzag-like junctions (Figure 11, B and C). At 
later stages, reduced and punctuated VE-cadherin staining was 
observed, demonstrating a disruption of intercellular junctions 
(Supplemental Figure 9A). This was in agreement with our in vitro 
observation of intercellular gaps formed in FOXC2KD cells under 
oscillatory and, to a lesser extent, laminar shear stress (Figure 4, 
B and F, and Supplemental Figure 9B). In addition, endothelial 
junction protein claudin5, which is highly expressed in wild-type 
collecting vessels, was also reduced in Foxc2lecKO degenerating 
valve areas (Supplemental Figure 9C).
We further examined the morphology of endothelial cell-cell 
junctions in the thoracic duct using transmission electron micros-
copy. In wild-type mice, endothelial cells formed a thin and con-
tinuous monolayer surrounded by a thick and dense basement 
membrane (Figure 11D). However, in Foxc2lecKO animals, the endo-
thelium appeared disrupted in several sites and associated with a 
loose and disorganized extracellular matrix, indicative of increased 
endothelial permeability (Figure 11D). Surprisingly, disruption of 
the endothelium was characterized by the formation of large vac-
uole-like structures, which formed thin sheet-like fragments shed-
ding into the lumen (Figure 11D). Further examination of cell-cell 
contacts revealed that wild-type endothelial cells had well-orga-
nized interdigitating contacts tightly bound to the matrix (Figure 11, 
E–G). However, the majority of such contacts in Foxc2lecKO cells were 
unfolded, resulting in the formation of large vacuoles and endothe-
lial cell detachment from the matrix below (Figure 11, D–G), indi-
cating severe loss of intercellular junction integrity.
Thus, we propose that loss of junction integrity in the absence 
of FOXC2 is responsible for lymph leakage and development of 
chylous effusion (Figure 10E). In addition, such vessels may be 
Foxc2lecKO adult mice displayed reduced resistance to increasing 
backflow pressures and leakiness (Figure 9B and Supplemental 
Figure 7, E and F) due to leaflet regression (Figure 9A).
Intraluminal valves, smooth muscle cell coverage, and lack 
of expression of lymphatic capillary markers, such as LYVE-1, 
are distinguishing features of collecting lymphatic vessels (6, 7). 
Lymphatic valve endothelial cells produce high levels of special-
ized extracellular matrix proteins, such as laminin α5 (24). Valve 
degeneration in Foxc2lecKO animals was associated with disruption 
and detachment of the laminin α5+ valve matrix (Figure 10A). 
Overall, smooth muscle cell recruitment to lymphangions was 
not significantly affected in Foxc2lecKO mice; in contrast, areas of 
degenerating valves were frequently covered with mural cells, 
while they were sparse in the valve areas of control mice (Fig-
ure 10B). Consistent with previous reports, LYVE-1 was virtually 
absent from the collecting vessels of wild-type mice (refs. 6, 9, 
25, and Figure 10C). However, we observed widespread ectopic 
reexpression of LYVE-1 in the mesenteric lymphatic vessels of 
Foxc2lecKO mice (Figure 10, C and D).
Taken together, these data demonstrate that FOXC2 is neces-
sary for postnatal development and maintenance of key charac-
teristics of the collecting vessels, such as intraluminal valves, pat-
terning of vascular smooth muscle cells, and appropriate vascular 
lumen size (Figure 10E).
FOXC2 controls cell shape and cell-cell junctions in vivo. Loss of 
valves in Foxc2lecKO mice demonstrates a critical role for FOXC2 not 
only in postnatal lymphatic valve development, but also in mainte-
nance. It also raises the question of whether regression of valve leaf-
lets is sufficient to explain the lethal phenotype of Foxc2lecKO mice. 
Gap junction protein connexin37 (CX37) is regulated by FOXC2 
during embryonic development, and Cx37–/– mice have severe 
impairment of lymphatic valve formation and lymph backflow (10, 
26). However, Cx37–/– mice, which lack lymphatic valves to the same 
extent as Foxc2lecKO animals, did not develop chylous ascites or chy-
lothorax and survived normally into adulthood (Supplemental Fig-
ure 8, A and B, and data not shown). Thus, while valve degeneration 
Figure 9. Characterization of functional defects in adult Foxc2lecKO valves. 
(A) Examples of wild-type and Foxc2lecKO valves from 8-week-old mice 
treated with tamoxifen for 4 weeks. Equal pressure was applied on both 
cannulated ends (Pin/Pout) to open the valve. Arrows indicate forward 
lymph flow direction. (B) Decreased resistance of Foxc2lecKO valves. Low 
pressure back-leak tests of mesenteric valves isolated from mice after 2 or 
4 weeks of Foxc2 inactivation (see also Supplemental Figure 7). n = 5 mice 
per group; 4–16 valves were scored per condition; 1-way ANOVA with Tukey-
Kramer post-hoc test; *P < 0.05. Scale bars: 40 μm.
Downloaded from http://www.jci.org on March 11, 2016.   http://dx.doi.org/10.1172/JCI80454
The Journal of Clinical Investigation   R e s e a R c h  a R t i c l e
3 8 7 1jci.org   Volume 125   Number 10   October 2015
nized PROX1hi apoptotic bodies (Figure 12, C and D), indicating that 
apoptosis might occur in dividing cells. To address this question, we 
stained wild-type and Foxc2lecKO mesenteries for PROX1 and the cell 
proliferation marker Ki67 to identify proliferating LECs that undergo 
cell death. Surprisingly, but in line with our in vitro results, a markedly 
higher proportion of PROX1+/Ki67+ cells was found in Foxc2lecKO col-
lecting vessels compared with that in control collecting vessels (Figure 
12E), demonstrating increased cell proliferation. Interestingly, 78.7% 
± 13.7% of the Foxc2lecKO valves (n = 3 animals) showed at least one 
cell death event, which was characterized by PROX1+ apoptotic bod-
ies (Figure 12F and ref. 28). Half of the Foxc2lecKO dying cells (50.6% 
± 27.9%, n = 3 animals; Figure 12G) were double positive for PROX1 
and Ki67, further reinforcing the link between cell proliferation and 
death in Foxc2lecKO vessels. In contrast, we were unable to detect dou-
ble-positive PROX1/Ki67 dying cells in the wild-type samples. We 
further validated the increased LEC proliferation in Foxc2lecKO vessels, 
using the EdU incorporation assay to detect DNA synthesis (Figure 
13, A and B). A significantly higher proportion of proliferating LECs 
less resistant to increased luminal pressure, stretch, and disturbed 
flow, all of which are prominent in valve sinuses (11). As a conse-
quence, Foxc2lecKO collecting vessels may become extremely frag-
ile at sites of degenerating valves and lumen obstruction (Figure 
7E), which may lead to vessel rupture and catastrophic lymph leak-
age or alternatively to compensatory collateral lymphatic vessel 
sprouting from obstructed valve sites (Figure 8C).
FOXC2 controls cell quiescence and survival in vivo. We next sought 
to investigate the cellular mechanisms implicated in valve regression 
and lumen collapse at the former valve site. The number of PROX1hi 
valve cells was reduced in Foxc2lecKO vessels already 2.5 days after 
tamoxifen administration (Supplemental Figure 10A and Supplemen-
tal Video 9). We examined LEC apoptosis in control and Foxc2lecKO 
mice by staining for activated caspase-3 and PROX1. While apoptosis 
was barely detectable in wild-type samples, a significant number of 
apoptotic cells were observed in the valves of Foxc2lecKO vessels (Fig-
ure 12, A and B). A careful examination revealed that Foxc2lecKO apop-
totic cells were often arranged in doublets with symmetrically orga-
Figure 10. FOXC2 maintains collecting lymphatic vessel phenotype. (A) Reduced valve core matrix in mesenteric lymphatic vessels of Foxc2lecKO P8 mice. 
Staining for laminin α5 (white) and PROX1 (red). The collecting vessel is outlined with dashed white lines. The arrow indicates sprout from the valve sinus. 
(B) Vascular smooth muscle cell coverage on mesenteric lymphatic valves of Foxc2lecKO P8 mice (arrowhead). Staining for αSMA (red) and PECAM1 (green). 
The collecting vessel is outlined with dashed white lines. B, blood vessel. (C) Increased levels of LYVE-1 (white) in collecting mesenteric lymphatic vessels 
of P8 Foxc2lecKO mice. Arrowheads indicate LYVE-1+ vessels. Some immune cells are also LYVE-1+ along the vascular branches. LN, lymph node. (D) Scheme 
recapitulating LYVE-1 staining shown in C. (E) Foxc2lecKO collecting vessels display valve regression, lumen collapse, and increased lymph leakage. Extreme 
narrowing of the vessel in the degenerating valve area could eventually lead to vessel rupture, precipitating accumulation of the lymph (e.g., in the pleural 
cavity). Scale bars: 20 μm (A and B); 500 μm (C).
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10E). Cx37 levels were decreased in Foxc2lecKO cells, in line with pre-
viously published results (Figure 13E, Supplemental Figure 10E, 
and refs. 10, 26). Most importantly, FOXC2-deficient valve LECs 
expressed higher levels of the YAP1/TAZ targets Ctgf, Cyr61, and 
Ankrd1, further supporting the notion that FOXC2 restricts TAZ 
activity in vivo (Figure 13F and Supplemental Figure 10E).
Collectively, these experiments suggest that FOXC2 is impor-
tant for the maintenance of collecting vessel endothelial cell qui-
escence and survival. In the absence of FOXC2, LECs undergo 
TAZ-dependent inappropriate proliferation, which is also accom-
panied by increased apoptosis, resulting in valve cell loss and ves-
sel lumen narrowing.
Inactivation of FOXC2 only in the valve areas recapitulates the 
postnatal lethality phenotype. Our in vitro data indicate that a com-
bination of FOXC2 loss of function and increased mechanical 
strain, such as OSS, is necessary to disrupt cell-cell junctions and to 
was found in Foxc2lecKO collecting vessels compared with that in con-
trol collecting vessels (Figure 13C), while lymphatic capillaries of both 
control and Foxc2lecKO mice displayed comparable proliferation rates 
(Supplemental Figure 10B).
Our in vitro experiments suggested that enhanced proliferation 
in the absence of FOXC2 is mediated by the increased activity of 
the Hippo pathway effector TAZ (Figure 6). Moreover, we observed 
TAZ nuclear localization in the lymphatic collecting vessels, par-
ticularly in valves (Figure 6D) and in Ki67+ LECs in Foxc2lecKO mice 
(Supplemental Figure 10C). To study TAZ activity in vivo, we iso-
lated lymphangion and lymphatic valve endothelial cells from 
the mesenteric vessels of wild-type or Foxc2lecKO Prox1-mOrange2 
animals using FACS (Supplemental Figure 10D). As expected, 
valve cells expressed higher levels of the mOrange2 transgene 
and valve markers Prox1, integrin α9, and Cx37 in comparison to 
lymphangion cells (Figure 13, D and E, and Supplemental Figure 
Figure 11. FOXC2 controls cell-cell junction integrity in 
collecting vessels. (A) Impaired cell elongation in Foxc2lecKO P7 
mesenteric collecting lymphatic vessels. Staining for VE-cad-
herin. Red arrowheads indicate lymphatic sprouts from valve 
sinuses. B, blood vessels. (B) Continuous VE-cadherin pattern 
in wild-type LECs and zigzag-like junctions in Foxc2lecKO LECs. 
The bottom row shows outline of the cells. B, blood capillary. 
(C) High-magnification images of the junctions from the pink 
boxed area in B. Foxc2lecKO junctions have multiple gaps (green 
arrowheads). (D) Transmission electron microscopy images of 
P8 wild-type and Foxc2lecKO thoracic duct transverse sections. 
L, lymphatic lumen; F, fibroblast; lec, endothelial nucleus; 
Co, collagen fibers. Asterisks indicate endothelial vacuoles; 
red arrowheads indicate sheet-like structures shedding 
into the lumen; pink arrows indicate basement membrane. 
The lymphatic endothelium is highlighted in blue. (E and F) 
Transmission electron microscopy images of LEC junctions in 
the thoracic duct. Neighboring cells (the left one is pseudo-
colored in pink) have “interdigitating” contacts, fixed on both 
ends by junctional complexes (red arrowheads in F) and to the 
basement membrane (BM) via adhesion complexes (arrows). 
Foxc2lecKO cell-cell contacts are unfolded, resulting in the 
formation of interendothelial vacuoles (asterisks), which often 
detach from the matrix below (double arrows). Co; collagen 
fibers; L, vessel lumen. A scheme of the intercellular junctions 
shown on the left in F is provided on the right. (G) Quantifica-
tion of endothelial cell-cell junction organization in the tho-
racic ducts of Foxc2lecKO and control mice. Percentage of tight 
(see wild-type junction in F) or loose (see Foxc2lecKO junction 
in F) cell-cell junctions is shown for each genotype together 
with the number of junctions analyzed (see also Supplemental 
Figure 9). Scale bars: 50 μm (A); 10 μm (B and C); 2 μm (D); 1 
μm (E); 250 nm (F).
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of the PROX1hi leaflet cells was in direct contact with the PROX1lo 
lymphangion cells (Supplemental Figure 11), junctional defects and 
the abnormal proliferation/apoptosis rate of such FOXC2-deficient 
PROX1hi cells likely lead not only to valve leaflet regression, but also 
to vessel wall disruption, lymph leakage, and subsequent mouse 
death. We therefore propose that lymphatic valve areas represent 
critically vulnerable regions in collecting lymphatic vessels, which 
require especially high levels of FOXC2 to ensure vessel integrity 
and normal function of the entire lymphatic vessel network.
Discussion
Quiescence, barrier integrity, and functional specialization are 
key properties of the postnatal vasculature. At present, little is 
known about the regulation of these traits in lymphatic vessels, 
despite increasing understanding of their importance in both nor-
mal physiology and many diseases, such as cancer, inflammation, 
obesity, hypertension, and atherosclerosis (4, 5). Our ability to 
therapeutically modulate lymphatic vascular function — and thus 
potentially treat some of the major diseases — needs better under-
standing of the molecular processes important for lymphatic vas-
cular stabilization, specialization, and maintenance. Here, we 
report that function of postnatal collecting lymphatic vessels criti-
cally depends on the transcription factor FOXC2.
By using an inducible loss-of-function genetic mouse model, 
we show that, in the absence of FOXC2, there is a rapid loss of 
collecting lymphatic vessel specialization and function. Such 
initiate abnormal cell proliferation and death, which would impair 
lymphatic vascular function in vivo. Therefore, inactivation of 
Foxc2 only in areas of disturbed flow, such as valves, should reca-
pitulate the lethal phenotype observed in mice with inactivation 
of Foxc2 in all LECs. To test this hypothesis, we generated Foxc2fl/fl 
Prox1-CreERT2 Rosa26-YFP and Prox1-CreERT2 Rosa26-YFP mice, in 
which administration of tamoxifen genetically marks recombined 
cells with YFP. We next titrated the dosage of tamoxifen to 3 μg/g to 
achieve a mosaic deletion of Foxc2 in P4 mice. At this concentration, 
recombination was observed only in 5% to 10% of cells, preferen-
tially in the valve areas, likely due to higher Prox1 promoter activity 
(Figure 14A). We quantified the number of YFP+ cells in the lym-
phatic vessels of control and Foxc2lecKO animals 2 days after tamox-
ifen injection, which was prior to the appearance of valve structure 
defects. There was a significant decrease in the number of YFP+ cells 
in Foxc2lecKO valves compared with that in wild-type valves, while 
YFP expression was comparable in other PROX1-expressing tissues, 
such as eye lenses, in the control and Foxc2lecKO mice (Figure 14 and 
data not shown). These data are in line with the observed increased 
apoptosis (Figure 12, A and B), and they confirm that Foxc2- 
deficient cells were rapidly eliminated from valve regions. Most 
importantly, such localized inactivation of FOXC2 resulted in the 
development of chylothorax and fully penetrant animal lethality 
(0 of 7 Foxc2lecKO mice vs. 6 of 6 control mice were alive 2 weeks after 
tamoxifen injection), thus recapitulating the defect of lymphatic 
vessels with complete inactivation of Foxc2. As a marked proportion 
Figure 12. FOXC2 maintains cell quiescence 
and survival in vivo. (A) Increased apoptosis 
in Foxc2lecKO lymphatic collecting vessels 2 
days after Foxc2 inactivation. Staining for 
PROX1 (red) and activated caspase-3 (green). 
Only rare CASP3+ nonendothelial cells were 
observed in the wild-type samples (inset). 
Dotted white lines outline the collecting 
vessel. (B) Quantification of PROX1+/
CASP3+ cells. n = 3–5; 5–10 valves scored 
per mesentery; 2-tailed unpaired Student’s 
t test; *P < 0.005. (C) High-magnification 
images of the area outlined by the yellow 
box in A. Foxc2lecKO apoptotic cells were often 
arranged in doublets with PROX1hi symmet-
rically organized apoptotic bodies (white 
arrowheads). (D) Proportion of PROX1+/
CASP3+ apoptotic cell doublets (blue) or 
singlets (red) in Foxc2lecKO mesenteries. WT, 
n = 2 animals; Foxc2lecKO, n = 4 animals. (E) 
Increased LEC proliferation in Foxc2lecKO col-
lecting vessels. Staining for Ki67 (green) and 
PROX1 (red) 3 days after Foxc2 inactivation. 
Dotted white lines outline collecting vessels. 
Blue arrowheads indicate PROX1+/Ki67+ cells. 
(F) High-magnification image of a dying LEC 
with a fragmented PROX1+/Ki67+ pattern 
(white arrowhead) from the area outlined 
by the yellow box in E. (G) Proportion of the 
PROX1+/Ki67+ double-positive apoptotic cells 
in Foxc2lecKO mesenteries. No PROX1+/Ki67+ 
apoptotic bodies were observed in wild-type 
mesenteries. n = 3 mice per genotype. Scale 
bars: 20 μm (A and E); 10 μm (C and F).
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15). Inactivation of FOXC2 leads to loss of mature intercellular junc-
tions and to actin cytoskeleton reorganization, which, we believe, 
is the initial defect that propagates lymphatic vascular dysfunction 
by several mechanisms. First, it impairs the collecting vessel bar-
rier function and promotes lymph leakage, directly accounting for 
the development of chylous effusion (Figure 7, B and C, and Figure 
15). Second, it modifies the responses of LECs to fluid shear stress: 
while disturbed flow promotes the quiescence of FOXC2+ LECs, in 
the absence of FOXC2, cells respond by activating TAZ signaling, 
which is further translated into enhanced cell proliferation followed 
by cell death (Figure 15). YAP1/TAZ are Hippo signaling effectors that 
play a key role in regulating organ size and tissue growth as well as in 
cancer (29, 30). However, the role of YAP1/TAZ in endothelial cells 
is not well understood. While YAP1 seems to have a dominant pro- 
proliferative function in most cell types, including HUVECs (31, 32), 
our analyses surprisingly revealed that, in LECs, TAZ, but not YAP1, is 
a critical regulator of proliferation in OSS and likely other conditions. 
Another intriguing observation is the fact that OSS induces not only 
FOXC2KD cell proliferation, but also cell death. Progression through 
the cell cycle requires highly coordinated changes in actin cytoskel-
changes are characterized by degeneration of the lymphatic 
valves, decreased vascular barrier properties, ectopic endothelial 
proliferation and apoptosis, and loss of a patent vascular lumen at 
the sites of former valves (Figure 15). FOXC2 is highly expressed 
in the lymphatic valve sinuses, which are constantly solicited by 
complex fluid flow patterns and mechanical stretch, due to valve 
opening and closure (Figure 15). In addition, the valve site lacks 
smooth muscle cells, which normally provide prosurvival and 
stabilizing signals to the vascular endothelium (e.g., Figure 10B). 
Thus, we propose that continuous high FOXC2 expression is crit-
ical for the stability and function of these regions and, ultimately, 
normal function of the entire lymphatic vascular network.
We have shown previously that FOXC2 expression is induced 
by OSS (10). Here, we propose a model for the self-organization and 
maintenance of lymphatic valve regions in which FOXC2 plays a cen-
tral role (Figure 15). In such a model, recirculating lymph flow, gen-
erated because of the geometry of the valves, induces high expres-
sion of FOXC2. FOXC2, in turn, maintains lymphatic valve leaflet 
and sinus integrity by stabilizing cell-cell junction and promoting 
quiescence and survival of cells subjected to disturbed flow (Figure 
Figure 13. FOXC2 promotes cell growth arrest and counteracts TAZ signaling. (A) Increased proliferation in Foxc2lecKO lymphatic collecting vessels. DNA syn-
thesis was detected by EdU incorporation 2 days after tamoxifen injection. Staining for PROX1 (white) and EdU (red). Dotted green lines outline the collecting 
vessel. (B) High-magnification images of the area in the yellow box from A (PROX1 staining only). The dashed red lines outline the EdU+ nuclei. Blue arrow-
heads indicate EdU+/PROX1+ nuclei; blue asterisks indicate EdU+/PROX1– nuclei. (C) Quantification of EdU+/PROX1+ cells in the collecting vessels of control 
or Foxc2lecKO mice. n = 9; 5 valves scored per mesentery; 2-tailed unpaired Student’s t test; *P < 0.01. (D) Orange transgene expression levels in mesenteric 
lymphangion (Orangelo) and valve cells (Orangehi) isolated from Prox1-mOrange2+ and Foxc2lecKO Prox1-mOrange2+ pups 2 days after tamoxifen injection. 
(E) Valve markers Prox1, Itga9, and Cx37 are elevated in Orangehi control LECs. Cx37 is reduced in Foxc2-deficient LECs, as reported previously (10, 26). (F) 
Enhanced expression of TAZ target genes Ctgf, Cyr61, and Ankrd1 in LECs of Foxc2lecKO mice. Data are representative of 2 independent experiments. The second 
experiment is shown in Supplemental Figure 10E (see also Supplemental Figure 10 and Supplemental Video 9). Scale bars: 50 μm (A); 100 μm (B).
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our work also reveals unexpected differences in the responses to the 
same mechanical stimuli by blood and LEC lineages. In addition, 
we suggest that further understanding of how lymphatic vessels 
avoid deleterious effects of disturbed fluid flow may provide useful 
information for the prevention or treatment of atherosclerosis.
Methods
Animal models. Generation of Foxc2fl/fl mice is described in Supplemental 
Figure 5A. Prox1-CreERT2, Flt4-CreERT2, Prox1-mOrange2, Rosa26-YFP, 
and Cx37–/– mice were described previously (Supplemental Figure 5B 
and refs. 23, 35–38). All mice were bred to at least the sixth generation 
on C57BL6/J background. Pups were injected with 125 μg tamoxifen in 
50 μl sunflower oil i.p. or subcutaneously (Supplemental Figure 5C). For 
mosaic deletion, we used 3 μg/g tamoxifen. Adult mice were treated for 2 
to 4 weeks, with 2 injections i.p. per week with 50 μg/g tamoxifen. 5 μg/g 
EdU (Life Technologies) was injected i.p. 3 hours prior to sacrifice.
Microlymphangiography. Anesthetized Prox1-mOrange2+ mice 
were injected with 2 μl of 10 mg/ml 4-kDa FITC-dextran (Sigma- 
Aldrich) into forelimb foot pads or lymph nodes. Lymphatic drainage 
was observed under a Leica M205FA stereomicroscope, using Leica 
camera DFC300FXR2 and LAS AF6000 software.
Mouse tissue collection, staining procedures, and image acquisition. 
See the Supplemental Methods for detailed information. Supplemen-
tal Table 2 lists primary and secondary antibodies and dyes used in the 
study. All whole-mount staining images are shown with the same ori-
entation, i.e., with the direction of flow from the bottom.
Adult valve back-leak test. Mesenteric lymphatic collecting vessel 
segments containing one valve were dissected from 8-week-old mice 
and analyzed as previously described (39, 40). A diagram of the prep-
aration is shown in Supplemental Figure 7C. Briefly, output pressure 
(downstream) was elevated while monitoring pressure and diameter 
on the input (upstream) side of the valve (Supplemental Figure 7D). 
Two tests were performed at low (0.5–10 cm H2O at a rate of 4 cm 
H2O/min) or high (10–60 cm H2O with each step lasting for 30 sec-
onds) pressure levels.
Transmission electron microscopy. Transmission electron micros-
copy was performed as previously described (41). Briefly, tissues were 
immersion fixed in 2.5% glutaraldehyde in PBS, post-fixed in osmium 
tetroxide, dehydrated in ethanol series, and embedded in epoxy resin. 
Ultrathin 90-nm sections were mounted on copper grids coated with 
Formvar (polyvinyl formal; Fluka), stained with lead citrate and uranyl 
acetate, and analyzed using a Philips EM 400 electron microscope.
eton; therefore, it is possible that the abnormal state of the cytoskel-
eton in FOXC2KD cells, which is especially striking in OSS (Figure 5), 
interferes with certain steps of cell division and leads to cell death.
In atherosclerosis, disturbed flow increases cell proliferation 
and apoptosis of blood arterial endothelial cells, leading to the for-
mation of distinct areas with increased expression of proinflamma-
tory genes and vascular permeability, which are thought to initiate 
the development of atherosclerotic plaques (33). While a side-by-
side comparison of responses of different types of BECs and LECs 
to a range of shear stress values still needs to be carried out, it is 
of interest that the responses of FOXC2-deficient LECs, such as 
increased proliferation and cell death, are reminiscent of the BEC 
behavior in atheroprone regions (2). Lymphatic valves are charac-
terized by disturbed flow, and the mouse mesenteric vessel network 
contains up to 800 valves. Thus, unlike in blood vessels, areas of low 
OSS are very common in collecting lymphatic vessels. We therefore 
postulate that lymphatic vessels evolved a protective mechanism to 
keep such regions quiescent and functional through the mechanoin-
duction of FOXC2. In the absence of FOXC2, LECs might revert to 
the blood endothelial-specific dysfunctional phenotype and there-
fore be unable to withstand the valve mechanical stress.
FOXC2 is mutated in the human disease of lymphatic vessels, 
lymphedema-distichiasis, characterized by swelling of the lower 
limbs and valve defects (8). Since FOXC2 controls a significant part 
of the mechanoresponses of LECs, it is tempting to suggest that 
abnormal mechanotransduction is the primary cause of the defects 
observed in patients with lymphedema-distichiasis. Although 25% 
of Foxc2+/– mice are reported to develop lymphatic vascular defects 
(34), such incomplete penetrance complicates testing of potential 
treatment approaches for lymphedema-distichiasis. The rapid 
and fully penetrant onset of lymphatic vascular dysfunction in our 
model makes it especially suitable for therapeutic preclinical stud-
ies, such as screening of pharmacological agents.
In summary, our work reveals a key role of FOXC2 in the sta-
bilization of collecting lymphatic vessels and maintenance of their 
function. It establishes a general principle of postnatal lymphatic 
vascular organization, in which the FOXC2 transcriptional network 
orchestrates collecting lymphatic vessel phenotype, quiescence, 
and integrity, through the coordination of cell-cell junction matura-
tion and shear stress responses in the regions of disturbed flow, such 
as valves. It also uncovers a novel crosstalk between FOXC2 and 
TAZ in the regulation of LEC quiescence and proliferation. Finally, 
Figure 14. FOXC2 protects valve 
cells in vivo. (A) Foxc2lecKO cells are 
not retained in the valves. Mesenter-
ies from Rosa26-YFP WT or Rosa26-
YFP Foxc2lecKO mice were stained 
for PROX1 (red) and GFP (white) 2 
days after Foxc2 mosaic deletion. 
Arrowheads indicate PROX1+/YFP+ 
cells. (B) Quantification of PROX1hi/
GFP+ (valve) and PROX1lo/GFP+ 
(lymphangion) cells in wild-type and 
Foxc2lecKO mesenteric vessels (see 
also Supplemental Figure 11). n = 3; 
5–10 valves scored per mesentery; 
2-tailed unpaired Student’s t test; 
*P < 0.05. Scale bars: 25 μm.
Downloaded from http://www.jci.org on March 11, 2016.   http://dx.doi.org/10.1172/JCI80454
The Journal of Clinical Investigation R e s e a R c h  a R t i c l e
3 8 7 6 jci.org   Volume 125   Number 10   October 2015
puted using the conditional hypergeometric test implemented in 
GOstat. ReviGO was used to summarize GO enrichment lists into 
groups, and redundant groups were merged into biologically relevant 
groups by manual curation.
Flow cytometry. P14 mouse mesenteries were digested using Colla-
genase A (1 mg/ml, Roche)/DNase I (100 μg/ml, Roche) solution with 
0.1% BSA. Cell suspension was filtered through a 40-μm cell strainer, 
washed with 5% FBS in phenol red-free DMEM (Gibco), and sorted 
on a BD FACSAria III (BD Biosciences) or MoFlo AstriosEQ (Beckman 
Coulter Life Sciences) cell sorter with BD FACSDiva software (BD 
Biosciences). Following exclusion of dead cells and multiplets, single 
mOrange2+ cells were gated using mOrange-PE and PE-TexasRed 
channels; cells from nontransgenic littermates were used to define the 
orange gate (Supplemental Figure 10D).
RNA isolation, qPCR, and Western blot analyses. For a full descrip-
tion, see the Supplemental Methods. A list of sequences of PCR prim-
ers is provided in Supplemental Table 4.
Quantification. For a full description, see the Supplemental Methods.
Statistics. We used a 2-tailed unpaired Student’s t test to deter-
mine statistical significance by calculating the probability of differ-
ence between two means. For valve back-leak test analyses, a custom 
LabVIEW program (National Instruments) was used to bin the data 
in 0.1- or 5-cm H2O increments for low- and high-pressure ramps, 
respectively. The binned data were imported into JMP 8 (SAS Insti-
tute) and analyzed using 1-way ANOVAs with Tukey-Kramer post-
hoc tests. The differences were considered statistically significant at 
P < 0.05. Data are shown as mean ± SD.
Study approval. Experiments were approved by the Animal Ethics 
Committee of Vaud, Switzerland, or by the University of Missouri Ani-
mal Care and Use Committee.
Cell transfection and immunostaining. Human intestinal LECs were 
cultured as described previously (42). See the Supplemental Methods 
for detailed information. Supplemental Table 2 lists primary and sec-
ondary antibodies and dyes used in the study. siRNAs are listed in Sup-
plemental Table 3. Two different siRNAs or a pool of four were used 
independently to knockdown the gene of interest. Knockdown effi-
ciency was confirmed for each siRNA by RT-qPCR, Western blot anal-
ysis, and/or immunostaining (Figure 3A and Supplemental Figure 1A 
for FOXC2; Supplemental Figure 2B for a second FOXC2 siRNA; Sup-
plemental Figure 4C for YAP1; and Supplemental Figure 4D for TAZ).
In vitro flow experiments. LECs were seeded at confluence on 
fibronectin-coated slides (μ-Slide I0.8 Luer; ibidi), cultured for 24 
hours, and subjected to oscillatory (4 dynes/cm2; 0.25 Hz, flow 
changes direction every 4 seconds) or laminar flow (4 dynes/cm2) in a 
parallel plate flow chamber system (ibidi Pump System; ibidi) or kept 
under static conditions for 48 hours. For full description, see the Sup-
plemental Methods.
Gene expression and bioinformatics analyses. RNA was isolated from 
FOXC2 or control siRNA-transfected LECs subjected to 24 hours of 
OSS (1 dyn/cm2; 0.25 Hz) or kept under static conditions in 2 indepen-
dent experiments using 2 different FOXC2 siRNAs. RNA was ampli-
fied and hybridized on Affymetrix Human Gene 1.0 ST Arrays, and 
arrays were scanned and analyzed as described previously (43). The 
data were corrected for batch effect with the COMBAT method and 
normalized using Robust Multichip Average (method Bioconductor 
package affy, R version 3.0.1). Data were submitted to Gene Omnibus 
Expression (NCBI) under the accession number GSM1466659.
Pathway analyses were performed using R packages String.db and 
GOstat. The igraph package was used for network layout obtained in 
String.db. Enrichment for GO (biological process) terms was com-
Figure 15. FOXC2 and fluid shear 
stress stabilize postnatal lymphatic 
vasculature by enhancing cell-cell 
junction integrity and inducing 
cell-cycle arrest. Collecting lymphatic 
vessels contain a large number of 
lymphatic valves, characterized by 
areas of persistent disturbed flow in 
valve sinuses. Disturbed flow (modeled 
by OSS) induces expression of FOXC2, 
formation of overlapping intercellular 
junctions, and nuclear accumulation of 
TAZ. FOXC2 protects integrity of the 
overlapping cell-cell junctions and the 
cortically organized actin cytoskeleton 
and prevents the proliferative action 
of TAZ. In the absence of FOXC2, 
OSS potentiates the cell-cell junction 
defects, activates cytoskeleton remod-
eling, and induces TAZ-dependent cell 
proliferation and death.
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